Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether an experimental anti-anxiety medication is effective in the treatment of Generalized Anxiety Disorder.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Jazz Pharmaceuticals
NCT06066983 · Autism Spectrum Disorder, Anxiety Disorders
NCT06968026 · Recurrent Pregnancy Loss, Anxiety Disorders
NCT07477990 · General Anxiety Disorder
NCT07174947 · Hepatobiliary Malignancy, Fluoxetine, and more
NCT07456631 · Social Anxiety Disorder (SAD), Oppositional Defiant Disorder
Birmingham Research Group, Inc.
Birmingham, Alabama
Crest Clinical Trials, Inc.
Anaheim, California
Southwesten Research, Inc.
Beverly Hills, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions